Detection and analysis of resistance mutations of hepatitis B virus

about

Single-virion sequencing of lamivudine-treated HBV populations reveal population evolution dynamics and demographic history

P2860

Q42609924-21C8111E-EA98-4985-9854-7CEF399CF48A

P2860

Detection and analysis of resistance mutations of hepatitis B virus

Item

http://www.wikidata.org/entity/Q28266666

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Detection and analysis of resistance mutations of hepatitis B virus

@ast

Detection and analysis of resistance mutations of hepatitis B virus

@en

Detection and analysis of resistance mutations of hepatitis B virus

@nl

type

Item

label

Detection and analysis of resistance mutations of hepatitis B virus

@ast

Detection and analysis of resistance mutations of hepatitis B virus

@en

Detection and analysis of resistance mutations of hepatitis B virus

@nl

prefLabel

Detection and analysis of resistance mutations of hepatitis B virus

@ast

Detection and analysis of resistance mutations of hepatitis B virus

@en

Detection and analysis of resistance mutations of hepatitis B virus

@nl

P1476

Detection and analysis of resistance mutations of hepatitis B virus

@en

P2093

Bin Huang

http://www.w3.org/2001/XMLSchema#string

Fang Wang

http://www.w3.org/2001/XMLSchema#string

Liangying Zhong

http://www.w3.org/2001/XMLSchema#string

Peisong Chen

http://www.w3.org/2001/XMLSchema#string

Xiaohong He

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine.

Chronic hepatitis B: Advances in treatment.

Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis.

Character of HBV (hepatitis B virus) polymerase gene rtM204V/I and rtL180M mutation in patients with lamivudine resistance.

Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic hepatitis B virus infection.

Management of antiviral resistance in patients with chronic hepatitis B.

Cellular and virological mechanisms of HBV drug resistance.

Emerging therapeutics for chronic hepatitis B.

Tenofovir (TDF) has stronger antiviral effect than adefovir (ADV) against lamivudine (LAM)-resistant hepatitis B virus (HBV)

Hepatitis B virus resistance to nucleos(t)ide analogues.

P304

9630-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26309637

http://www.w3.org/2001/XMLSchema#string

P932

4538069

http://www.w3.org/2001/XMLSchema#string